Draelos ZD - Search Results

1

Pilot study: Autologous platelet-rich plasma used in a topical cream for facial rejuvenation.

Draelos ZD, Rheins LA, Wootten S, Kellar RS, Diller RB. Draelos ZD, et al. J Cosmet Dermatol. 2019 Oct;18(5):1348-1352. doi: 10.1111/jocd.13088. Epub 2019 Jul 26. J Cosmet Dermatol. 2019. PMID: 31350798 Free PMC article.

2

An evaluation of electrocoagulation and thermal diffusion following radiofrequency microneedling using an in vivo porcine skin model.

Wootten S, Zawacki ZE, Rheins L, Meschter C, Draelos ZD. Wootten S, et al. Among authors: draelos zd. J Cosmet Dermatol. 2021 Apr;20(4):1133-1139. doi: 10.1111/jocd.13690. Epub 2020 Sep 7. J Cosmet Dermatol. 2021. PMID: 32846042 Free PMC article.

3

Topically delivered dissolved oxygen reduces inflammation and positively influences structural proteins in healthy intact human skin.

Kellar RS, Audet RG, Roe DF, Rheins LA, Draelos ZD. Kellar RS, et al. Among authors: draelos zd. J Cosmet Dermatol. 2013 Jun;12(2):86-95. doi: 10.1111/jocd.12039. J Cosmet Dermatol. 2013. PMID: 23725301 Clinical Trial.

4

The Role of Platelet Homeostasis in a Novel Topical PRP Formulation.

Wooten S, Draelos ZD, Kellar RS, Rheins L. Wooten S, et al. Among authors: draelos zd. J Drugs Dermatol. 2020 Dec 1;19(12):1215-1218. doi: 10.36849/JDD.2020.5495. J Drugs Dermatol. 2020. PMID: 33346518 Clinical Trial.

5

A novel skin brightening topical technology.

Draelos ZD, Diaz I, Cohen A, Mao J, Boyd T. Draelos ZD, et al. J Cosmet Dermatol. 2020 Dec;19(12):3280-3285. doi: 10.1111/jocd.13741. Epub 2020 Oct 12. J Cosmet Dermatol. 2020. PMID: 32985076 Free PMC article.

6

Efficacy and safety of silymarin containing antioxidant serum as an adjuvant treatment of mild-to-moderate acne vulgaris: A prospective, open-label pilot study.

Kim J, Lee YN, Lee J, Lee SG, Kim H, Choi YS, Draelos ZD, Kim J. Kim J, et al. Among authors: draelos zd. J Cosmet Dermatol. 2023 Feb;22(2):561-568. doi: 10.1111/jocd.15439. Epub 2022 Oct 31. J Cosmet Dermatol. 2023. PMID: 36204969

7

Dyspigmentation, skin physiology, and a novel approach to skin lightening.

Draelos Z, Dahl A, Yatskayer M, Chen N, Krol Y, Oresajo C. Draelos Z, et al. J Cosmet Dermatol. 2013 Dec;12(4):247-53. doi: 10.1111/jocd.12066. J Cosmet Dermatol. 2013. PMID: 24305422 Clinical Trial.

8

A pilot study investigating the efficacy of botanical anti-inflammatory agents in an OTC eczema therapy.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2016 Jun;15(2):117-9. doi: 10.1111/jocd.12199. Epub 2015 Nov 24. J Cosmet Dermatol. 2016. PMID: 26596512

9

An effective hydroquinone alternative for topical skin lightening.

Draelos ZD, Deliencourt-Godefroy G, Lopes L. Draelos ZD, et al. J Cosmet Dermatol. 2020 Dec;19(12):3258-3261. doi: 10.1111/jocd.13771. Epub 2020 Nov 16. J Cosmet Dermatol. 2020. PMID: 33098161 Clinical Trial.

10

An evaluation of the effect of a topical product containing C-xyloside and blueberry extract on the appearance of type II diabetic skin.

Draelos ZD, Yatskayer M, Raab S, Oresajo C. Draelos ZD, et al. J Cosmet Dermatol. 2009 Jun;8(2):147-51. doi: 10.1111/j.1473-2165.2009.00428.x. J Cosmet Dermatol. 2009. PMID: 19527341 Clinical Trial.

11

Triamcinolone spray: no-rub application as effective as rub application.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2015 Dec;14(4):286-90. doi: 10.1111/jocd.12161. Epub 2015 Jul 1. J Cosmet Dermatol. 2015. PMID: 26133561 Clinical Trial.

12

Hydrophobically modified polymers can minimize skin irritation potential caused by surfactant-based cleansers.

Draelos Z, Hornby S, Walters RM, Appa Y. Draelos Z, et al. J Cosmet Dermatol. 2013 Dec;12(4):314-21. doi: 10.1111/jocd.12061. J Cosmet Dermatol. 2013. PMID: 24305430 Free PMC article. Clinical Trial.

13

Novel retinoid ester in combination with salicylic acid for the treatment of acne.

Draelos Z, Lewis J, McHugh L, Pellegrino A, Popescu L. Draelos Z, et al. J Cosmet Dermatol. 2016 Mar;15(1):36-42. doi: 10.1111/jocd.12190. Epub 2015 Oct 30. J Cosmet Dermatol. 2016. PMID: 26516077

14

The ability of onion extract gel to improve the cosmetic appearance of postsurgical scars.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2008 Jun;7(2):101-4. doi: 10.1111/j.1473-2165.2008.00371.x. J Cosmet Dermatol. 2008. PMID: 18482012 Clinical Trial.

15

Five-day study to judge the short-term effect of a benzoyl peroxide 3% gel on acne lesions.

Draelos ZD, Ertel K, Rom D. Draelos ZD, et al. J Cosmet Dermatol. 2016 Dec;15(4):350-357. doi: 10.1111/jocd.12251. Epub 2016 Aug 3. J Cosmet Dermatol. 2016. PMID: 27489202 Clinical Trial.

16

A clinical evaluation of a permanent hair dye designed to reduce allergic contact dermatitis and hair damage.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2022 Sep;21(9):3925-3928. doi: 10.1111/jocd.15212. Epub 2022 Jul 19. J Cosmet Dermatol. 2022. PMID: 35790071 Free PMC article.

17

Efficacy Evaluation of a Topical Hyaluronic Acid Serum in Facial Photoaging.

Draelos ZD, Diaz I, Namkoong J, Wu J, Boyd T. Draelos ZD, et al. Dermatol Ther (Heidelb). 2021 Aug;11(4):1385-1394. doi: 10.1007/s13555-021-00566-0. Epub 2021 Jun 26. Dermatol Ther (Heidelb). 2021. PMID: 34176098 Free PMC article.

18

Protective effects of a novel nutritional and phytonutrient blend on ultraviolet radiation-induced skin damage and inflammatory response through aging defense mechanisms.

Wood SM, Mastaloudis AF, Hester SN, Gray R, Kern D, Namkoong J, Draelos ZD. Wood SM, et al. Among authors: draelos zd. J Cosmet Dermatol. 2017 Dec;16(4):491-499. doi: 10.1111/jocd.12295. Epub 2016 Nov 24. J Cosmet Dermatol. 2017. PMID: 27885783

19

A clinical evaluation of the comparable efficacy of hyaluronic acid-based foam and ceramide-containing emulsion cream in the treatment of mild-to-moderate atopic dermatitis.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2011 Sep;10(3):185-8. doi: 10.1111/j.1473-2165.2011.00568.x. J Cosmet Dermatol. 2011. PMID: 21896129 Clinical Trial.

20

The science behind skin care: Cleansers.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2018 Feb;17(1):8-14. doi: 10.1111/jocd.12469. Epub 2017 Dec 12. J Cosmet Dermatol. 2018. PMID: 29231284 Review.

21

The science behind skin care: Moisturizers.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2018 Apr;17(2):138-144. doi: 10.1111/jocd.12490. Epub 2018 Jan 10. J Cosmet Dermatol. 2018. PMID: 29319217 Review.

22

Examining 15% Azelaic Acid Foam for the Treatment of Folliculitis: A Pilot Study.

Draelos ZD. Draelos ZD. J Clin Aesthet Dermatol. 2020 Apr;13(4):36-38. Epub 2020 Apr 1. J Clin Aesthet Dermatol. 2020. PMID: 33144909 Free PMC article.

23

An evaluation of prescription device moisturizers.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2009 Mar;8(1):40-3. doi: 10.1111/j.1473-2165.2009.00422.x. J Cosmet Dermatol. 2009. PMID: 19250165 Clinical Trial.

24

An Oral Supplement and the Nutrition-Skin Connection.

Draelos ZD. Draelos ZD. J Clin Aesthet Dermatol. 2019 Jul;12(7):13-16. Epub 2019 Jul 1. J Clin Aesthet Dermatol. 2019. PMID: 31531157 Free PMC article.

25

A novel ultraviolet photography technique for assessing photodamage.

Draelos ZD, Klein G, Biancone G. Draelos ZD, et al. J Cosmet Dermatol. 2008 Sep;7(3):205-9. doi: 10.1111/j.1473-2165.2008.00390.x. J Cosmet Dermatol. 2008. PMID: 18789056

26

Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial.

Draelos ZD, Gold MH, Weiss RA, Baumann L, Grekin SK, Robinson DM, Kempers SE, Alvandi N, Weng E, Berk DR, Ahluwalia G. Draelos ZD, et al. J Am Acad Dermatol. 2018 Jun;78(6):1156-1163. doi: 10.1016/j.jaad.2018.01.027. Epub 2018 Jan 31. J Am Acad Dermatol. 2018. PMID: 29409914 Free article. Clinical Trial.

27

The Efficacy of a Ceramide-based Cream in Mild-to-moderate Atopic Dermatitis.

Draelos ZD, Raymond I. Draelos ZD, et al. J Clin Aesthet Dermatol. 2018 May;11(5):30-32. Epub 2018 May 1. J Clin Aesthet Dermatol. 2018. PMID: 29785236 Free PMC article.

28

Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne.

Blume-Peytavi U, Fowler J, Kemény L, Draelos Z, Cook-Bolden F, Dirschka T, Eichenfield L, Graeber M, Ahmad F, Alió Saenz A, Rich P, Tanghetti E. Blume-Peytavi U, et al. J Eur Acad Dermatol Venereol. 2020 Jan;34(1):166-173. doi: 10.1111/jdv.15794. Epub 2019 Aug 20. J Eur Acad Dermatol Venereol. 2020. PMID: 31306527 Free PMC article. Clinical Trial.

29

A novel topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: Results of 2 randomized, double-blind, phase 3 studies.

Gold LS, Dhawan S, Weiss J, Draelos ZD, Ellman H, Stuart IA. Gold LS, et al. Among authors: draelos zd. J Am Acad Dermatol. 2019 Jan;80(1):168-177. doi: 10.1016/j.jaad.2018.08.020. Epub 2018 Aug 27. J Am Acad Dermatol. 2019. PMID: 30165171 Clinical Trial.

30

Crisaborole Topical Ointment, 2% in Patients Ages 2 to 17 Years with Atopic Dermatitis: A Phase 1b, Open-Label, Maximal-Use Systemic Exposure Study.

Zane LT, Kircik L, Call R, Tschen E, Draelos ZD, Chanda S, Van Syoc M, Hebert AA. Zane LT, et al. Among authors: draelos zd. Pediatr Dermatol. 2016 Jul;33(4):380-7. doi: 10.1111/pde.12872. Epub 2016 May 18. Pediatr Dermatol. 2016. PMID: 27193740 Free PMC article. Clinical Trial.

31

A pilot study evaluating the efficacy of topically applied niacin derivatives for treatment of female pattern alopecia.

Draelos ZD, Jacobson EL, Kim H, Kim M, Jacobson MK. Draelos ZD, et al. J Cosmet Dermatol. 2005 Dec;4(4):258-61. doi: 10.1111/j.1473-2165.2005.00201.x. J Cosmet Dermatol. 2005. PMID: 17168873

32

A multicentre, randomized, double-masked, parallel group, vehicle-controlled phase IIb study to evaluate the safety and efficacy of 1% and 3% topical minocycline gel in patients with papulopustular rosacea.

Webster G, Draelos ZD, Graber E, Lee MS, Dhawan S, Salman M, Magrath GN. Webster G, et al. Among authors: draelos zd. Br J Dermatol. 2020 Sep;183(3):471-479. doi: 10.1111/bjd.18857. Epub 2020 Apr 14. Br J Dermatol. 2020. PMID: 31907924 Free PMC article. Clinical Trial.

33

A Randomized, Double-blind, Vehicle-controlled Trial of Luliconazole Cream 1% in the Treatment of Interdigital Tinea Pedis.

Draelos ZD, Vlahovic TC, Gold MH, Parish LC, Korotzer A. Draelos ZD, et al. J Clin Aesthet Dermatol. 2014 Oct;7(10):20-7. J Clin Aesthet Dermatol. 2014. PMID: 25371767 Free PMC article.

34

Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis: a phase IIb, randomized, double-blind, vehicle-controlled, dose-ranging and parallel-group study.

Landis MN, Arya M, Smith S, Draelos Z, Usdan L, Tarabar S, Pradhan V, Aggarwal S, Banfield C, Peeva E, Vincent MS, Sikirica V, Xenakis J, Beebe JS. Landis MN, et al. Br J Dermatol. 2022 Dec;187(6):878-887. doi: 10.1111/bjd.21826. Epub 2022 Oct 23. Br J Dermatol. 2022. PMID: 35986699 Clinical Trial.

35

An evaluation of topical 3% salicylic acid and 1% hydrocortisone in the maintenance of scalp pruritus.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2005 Sep;4(3):193-7. doi: 10.1111/j.1473-2165.2005.00311.x. J Cosmet Dermatol. 2005. PMID: 17129266

36

The facial rejuvenation algorithm.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2006 Sep;5(3):195. doi: 10.1111/j.1473-2165.2006.00265.x. J Cosmet Dermatol. 2006. PMID: 17177739 No abstract available.

37

Efficacy of hydroquinone-free skin-lightening cream for photoaging.

Dreher F, Draelos ZD, Gold MH, Goldman MP, Fabi SG, Puissegur Lupo ML. Dreher F, et al. Among authors: draelos zd. J Cosmet Dermatol. 2013 Mar;12(1):12-7. doi: 10.1111/jocd.12025. J Cosmet Dermatol. 2013. PMID: 23438137

38

A 14-day Controlled Study Assessing Qualitative Improvement with 15% Lactic Acid and Ceramides in Skin Moisturization and Desquamation.

Draelos ZD, Hall S, Munsick C. Draelos ZD, et al. J Clin Aesthet Dermatol. 2020 Aug;13(8):E54-E58. Epub 2020 Aug 1. J Clin Aesthet Dermatol. 2020. PMID: 33178384 Free PMC article.

39

The impact of cosmetic dermatology on skin care and cosmetics.

Draelos ZD. Draelos ZD. J Cosmet Sci. 2004 Mar-Apr;55(2):209-10. J Cosmet Sci. 2004. PMID: 15190892 No abstract available.

40

Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison.

Draelos Z, Nayak A, Pariser D, Shupack JL, Chon K, Abrams B, Paul CF. Draelos Z, et al. J Am Acad Dermatol. 2005 Oct;53(4):602-9. doi: 10.1016/j.jaad.2005.06.013. J Am Acad Dermatol. 2005. PMID: 16198779 Clinical Trial.

41

Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.

Stein Gold L, Baldwin H, Kircik LH, Weiss JS, Pariser DM, Callender V, Lain E, Gold M, Beer K, Draelos Z, Sadick N, Pillai R, Bhatt V, Tanghetti EA. Stein Gold L, et al. Am J Clin Dermatol. 2022 Jan;23(1):93-104. doi: 10.1007/s40257-021-00650-3. Epub 2021 Oct 21. Am J Clin Dermatol. 2022. PMID: 34674160 Free PMC article. Clinical Trial.

42

Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX101 4% Minocycline Foam for Moderate-to-Severe Acne Vulgaris.

Stein Gold L, Dhawan S, Weiss J, Draelos ZD, Ellman H, Stuart I. Stein Gold L, et al. Among authors: draelos zd. J Clin Aesthet Dermatol. 2019 Oct;12(10):16-23. Epub 2019 Oct 1. J Clin Aesthet Dermatol. 2019. PMID: 32038744 Free PMC article.

43

BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris.

Alexis A, Del Rosso JQ, Desai SR, Downie JB, Draelos ZD, Feser C, Forconi R, Fowler JF Jr, Gold M, Kaufman-Janette J, Lain E, Lee M, Ling M, Shamban AT, Werschler WP, Daniels A. Alexis A, et al. Among authors: draelos zd. J Clin Aesthet Dermatol. 2018 Nov;11(11):25-35. Epub 2018 Nov 1. J Clin Aesthet Dermatol. 2018. PMID: 30588271 Free PMC article.

44

A split-face evaluation of a novel pigment-lightening agent compared with no treatment and hydroquinone.

Draelos ZD. Draelos ZD. J Am Acad Dermatol. 2015 Jan;72(1):105-7. doi: 10.1016/j.jaad.2014.09.011. Epub 2014 Oct 16. J Am Acad Dermatol. 2015. PMID: 25440437 Clinical Trial.

45

Facial skin care products and cosmetics.

Draelos ZD. Draelos ZD. Clin Dermatol. 2014 Nov-Dec;32(6):809-12. doi: 10.1016/j.clindermatol.2014.02.020. Epub 2014 Oct 29. Clin Dermatol. 2014. PMID: 25441474 Review.

46

Publishing the nuisance negative study.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2008 Mar;7(1):1. doi: 10.1111/j.1473-2165.2008.00353.x. J Cosmet Dermatol. 2008. PMID: 18254803 No abstract available.

47

Cosmeceuticals: undefined, unclassified, and unregulated.

Draelos ZD. Draelos ZD. Clin Dermatol. 2009 Sep-Oct;27(5):431-4. doi: 10.1016/j.clindermatol.2009.05.005. Clin Dermatol. 2009. PMID: 19695473 Review.

48

Efficacy and safety of the Janus kinase 1 inhibitor PF-04965842 in patients with moderate-to-severe psoriasis: phase II, randomized, double-blind, placebo-controlled study.

Schmieder GJ, Draelos ZD, Pariser DM, Banfield C, Cox L, Hodge M, Kieras E, Parsons-Rich D, Menon S, Salganik M, Page K, Peeva E. Schmieder GJ, et al. Among authors: draelos zd. Br J Dermatol. 2018 Jul;179(1):54-62. doi: 10.1111/bjd.16004. Epub 2018 Mar 6. Br J Dermatol. 2018. PMID: 28949012 Clinical Trial.

49

The Efficacy and Tolerability of Turmeric and Salicylic Acid in Psoriasis Treatment.

Draelos ZD. Draelos ZD. Psoriasis (Auckl). 2022 Apr 29;12:63-71. doi: 10.2147/PTT.S360448. eCollection 2022. Psoriasis (Auckl). 2022. PMID: 35516971 Free PMC article.

50

Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study.

Gribetz C, Ling M, Lebwohl M, Pariser D, Draelos Z, Gottlieb AB, Zaias N, Chen DM, Parneix-Spake A, Hultsch T, Menter A. Gribetz C, et al. J Am Acad Dermatol. 2004 Nov;51(5):731-8. doi: 10.1016/j.jaad.2004.06.010. J Am Acad Dermatol. 2004. PMID: 15523351 Clinical Trial.

51

A Randomized, Controlled Trial of Trifarotene Plus Doxycycline for Severe Acne Vulgaris.

Del Rosso JQ, Johnson SM, Schlesinger T, Green L, Sanchez N, Lain E, Draelos Z, York JP, Chavda R. Del Rosso JQ, et al. J Clin Aesthet Dermatol. 2022 Jul;15(7):E53-E59. J Clin Aesthet Dermatol. 2022. PMID: 35942016 Free PMC article.

52

The effect of 2% niacinamide on facial sebum production.

Draelos ZD, Matsubara A, Smiles K. Draelos ZD, et al. J Cosmet Laser Ther. 2006 Jun;8(2):96-101. doi: 10.1080/14764170600717704. J Cosmet Laser Ther. 2006. PMID: 16766489 Clinical Trial.

53

Moisturizing cream ameliorates dryness and desquamation in participants not receiving topical psoriasis treatment.

Draelos ZD. Draelos ZD. Cutis. 2008 Sep;82(3):211-6. Cutis. 2008. PMID: 18856161

54

Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening.

Draelos ZD, Yatskayer M, Bhushan P, Pillai S, Oresajo C. Draelos ZD, et al. Cutis. 2010 Sep;86(3):153-8. Cutis. 2010. PMID: 21049734 Clinical Trial.

55

New and Emerging Treatments for Rosacea.

Gold LM, Draelos ZD. Gold LM, et al. Among authors: draelos zd. Am J Clin Dermatol. 2015 Dec;16(6):457-61. doi: 10.1007/s40257-015-0156-2. Am J Clin Dermatol. 2015. PMID: 26396117 Review.

56

Cosmeceuticals for rosacea.

Draelos ZD. Draelos ZD. Clin Dermatol. 2017 Mar-Apr;35(2):213-217. doi: 10.1016/j.clindermatol.2016.10.017. Epub 2016 Oct 27. Clin Dermatol. 2017. PMID: 28274362

57

Disclosure: a modest proposal.

Draelos ZD. Draelos ZD. Clin Dermatol. 2009 Jul-Aug;27(4):336-8. doi: 10.1016/j.clindermatol.2009.02.003. Clin Dermatol. 2009. PMID: 19539158

58

Five-year efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2).

Thaci D, Piaserico S, Warren RB, Gupta AK, Cantrell W, Draelos Z, Foley P, Igarashi A, Langley RG, Asahina A, Young M, Falqués M, Pau-Charles I, Mendelsohn AM, Rozzo SJ, Reich K. Thaci D, et al. Br J Dermatol. 2021 Aug;185(2):323-334. doi: 10.1111/bjd.19866. Epub 2021 May 4. Br J Dermatol. 2021. PMID: 33544883 Clinical Trial.

59

Degradation and migration of facial foundations.

Draelos ZD. Draelos ZD. J Am Acad Dermatol. 2001 Oct;45(4):542-3. doi: 10.1067/mjd.2001.116222. J Am Acad Dermatol. 2001. PMID: 11568744

60

Top 10 botanical ingredients in 2010 anti-aging creams.

Cronin H, Draelos ZD. Cronin H, et al. Among authors: draelos zd. J Cosmet Dermatol. 2010 Sep;9(3):218-25. doi: 10.1111/j.1473-2165.2010.00516.x. J Cosmet Dermatol. 2010. PMID: 20883295

61

New treatments for restoring impaired epidermal barrier permeability: skin barrier repair creams.

Draelos ZD. Draelos ZD. Clin Dermatol. 2012 May-Jun;30(3):345-8. doi: 10.1016/j.clindermatol.2011.08.018. Clin Dermatol. 2012. PMID: 22507050

62

A Double-Blind Randomized Pilot Study Evaluating the Safety and Efficacy of Topical MEP in the Facial Appearance Improvement of Estrogen Deficient Females.

Draelos ZD. Draelos ZD. J Drugs Dermatol. 2018 Nov 1;17(11):1186 - 1189. J Drugs Dermatol. 2018. PMID: 30500138 Clinical Trial.

63

Botanicals as topical agents.

Draelos ZD. Draelos ZD. Clin Dermatol. 2001 Jul-Aug;19(4):474-7. doi: 10.1016/s0738-081x(01)00187-0. Clin Dermatol. 2001. PMID: 11535391 Review. No abstract available.

64

An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients.

Draelos ZD, Green BA, Edison BL. Draelos ZD, et al. J Cosmet Dermatol. 2006 Mar;5(1):23-9. doi: 10.1111/j.1473-2165.2006.00219.x. J Cosmet Dermatol. 2006. PMID: 17173568 Clinical Trial. No abstract available.

65

Stratum corneum absorption kinetics of 2 potent topical corticosteroid formulations: a pilot study.

Draelos ZD. Draelos ZD. Cutis. 2015 Aug;96(2):135-41. Cutis. 2015. PMID: 26367752

66

A multicenter, double-blind study to evaluate the efficacy and safety of 2 treatments in participants with mild to moderate acne vulgaris.

Draelos ZD, Shalita AR, Thiboutot D, Oresajo C, Yatskayer M, Raab S. Draelos ZD, et al. Cutis. 2012 Jun;89(6):287-93. Cutis. 2012. PMID: 22838094 Clinical Trial.

67

A method for maintaining the clinical results of 4% hydroquinone and 0.025% tretinoin with a cosmeceutical formulation.

Draelos ZD, Raab S, Yatskayer M, Chen N, Krol Y, Oresajo C. Draelos ZD, et al. J Drugs Dermatol. 2015 Apr;14(4):386-90. J Drugs Dermatol. 2015. PMID: 25844613 Clinical Trial.

68

The Effect of a Ceramide-Containing Product on Stratum Corneum Lipid Levels in Dry Legs.

Draelos ZD, Baalbaki NH, Raab S, Colón G. Draelos ZD, et al. J Drugs Dermatol. 2020 Apr 1;19(4):372-376. doi: 10.36849/JDD.2020.4796. J Drugs Dermatol. 2020. PMID: 32272513 Clinical Trial.

69

A Double-Blind, Comparative Clinical Study of Newly Formulated Retinol Serums vs Tretinoin Cream in Escalating Doses: A Method for Rapid Retinization With Minimized Irritation.

Draelos ZD, Peterson RS. Draelos ZD, et al. J Drugs Dermatol. 2020 Jun 1;19(6):625-631. doi: 10.36849/JDD.2020.10.36849/JDD.2020.5085. J Drugs Dermatol. 2020. PMID: 32574009 Clinical Trial.

70

Skin lightening preparations and the hydroquinone controversy.

Draelos ZD. Draelos ZD. Dermatol Ther. 2007 Sep-Oct;20(5):308-13. doi: 10.1111/j.1529-8019.2007.00144.x. Dermatol Ther. 2007. PMID: 18045355 Review.

71

Aging skin: the role of diet: facts and controversies.

Draelos ZD. Draelos ZD. Clin Dermatol. 2013 Nov-Dec;31(6):701-6. doi: 10.1016/j.clindermatol.2013.05.005. Clin Dermatol. 2013. PMID: 24160273

72

The Role of a Natural Mollusk Egg-Derived Ingredient in Facial Appearance.

Draelos ZD. Draelos ZD. J Drugs Dermatol. 2017 Jul 1;16(7):678-681. J Drugs Dermatol. 2017. PMID: 28697219

73

The effect of ceramide-containing skin care products on eczema resolution duration.

Draelos ZD. Draelos ZD. Cutis. 2008 Jan;81(1):87-91. Cutis. 2008. PMID: 18306855 Clinical Trial.

74

Evaluation of the Performance of a Nature-Based Sensitive Skin Regimen in Subjects With Clinically Diagnosed Sensitive Skin.

Draelos ZD, Levy SB, Lutrario C, Gunt H. Draelos ZD, et al. J Drugs Dermatol. 2018 Aug 1;17(8):908-913. J Drugs Dermatol. 2018. PMID: 30124733 Clinical Trial.

75

Controlling reactive oxygen species in skin at their source to reduce skin aging.

Kern DG, Draelos ZD, Meadows C, James Morré D, Morré DM. Kern DG, et al. Among authors: draelos zd. Rejuvenation Res. 2010 Apr-Jun;13(2-3):165-7. doi: 10.1089/rej.2009.0914. Rejuvenation Res. 2010. PMID: 19954332

76

The cosmeceutical realm.

Draelos ZD. Draelos ZD. Clin Dermatol. 2008 Nov-Dec;26(6):627-32. doi: 10.1016/j.clindermatol.2007.09.005. Clin Dermatol. 2008. PMID: 18940543

77

Demonstration of the Antioxidant Capabilities of a Product Formulated With Antioxidants Stabilized in Their Reduced Form.

Draelos ZD, Pachuk CJ. Draelos ZD, et al. J Drugs Dermatol. 2020 Jan 1;19(1):46-49. doi: 10.36849/JDD.2020.3947. J Drugs Dermatol. 2020. PMID: 31985911

78

Therapeutic moisturizers.

Draelos ZD. Draelos ZD. Dermatol Clin. 2000 Oct;18(4):597-607. doi: 10.1016/s0733-8635(05)70210-2. Dermatol Clin. 2000. PMID: 11059367 Review.

79

The Effect of an Anti-Inflammatory Botanical Cleanser/Night Mask Combination on Facial Redness Reduction.

Draelos ZD, Donald A. Draelos ZD, et al. J Drugs Dermatol. 2018 Jun 1;17(6):671-676. J Drugs Dermatol. 2018. PMID: 29879255

80

The effect of two skin cleansing systems on moderate xerotic eczema.

Draelos ZD, Ertel K, Hartwig P, Rains G. Draelos ZD, et al. J Am Acad Dermatol. 2004 Jun;50(6):883-8. doi: 10.1016/j.jaad.2003.11.047. J Am Acad Dermatol. 2004. PMID: 15153888 Clinical Trial.

81

Revisiting the Skin Health and Beauty Pyramid: A Clinically Based Guide to Selecting Topical Skincare Products.

Draelos ZD. Draelos ZD. J Drugs Dermatol. 2021 Jun 1;20(6):695-699. doi: 10.36849/JDD.2021.5883. J Drugs Dermatol. 2021. PMID: 34076396

82

Cosmetic treatment of nails.

Draelos ZD. Draelos ZD. Clin Dermatol. 2013 Sep-Oct;31(5):573-7. doi: 10.1016/j.clindermatol.2013.06.008. Clin Dermatol. 2013. PMID: 24079586

83

The Effect of a Combination of Recombinant EGF Cosmetic Serum and a Crosslinked Hyaluronic Acid Serum as Compared to a Fibroblast-Conditioned Media Serum on the Appearance of Aging Skin.

Draelos ZD. Draelos ZD. J Drugs Dermatol. 2016 Jun 1;15(6):738-41. J Drugs Dermatol. 2016. PMID: 27272082

84

The Anti-Aging Effects of Low Oxygen Tension Generated Multipotent Growth Factor Containing Serum.

Draelos ZD, Karnik J, Naughton G. Draelos ZD, et al. J Drugs Dermatol. 2017 Jan 1;16(1):30-34. J Drugs Dermatol. 2017. PMID: 28095530

85

Age-related NADH oxidase (arNOX)-catalyzed oxidative damage to skin proteins.

Meadows C, Morré DJ, Morré DM, Draelos ZD, Kern D. Meadows C, et al. Among authors: draelos zd. Arch Dermatol Res. 2014 Sep;306(7):645-52. doi: 10.1007/s00403-014-1472-8. Epub 2014 Jun 7. Arch Dermatol Res. 2014. PMID: 24906676

86

Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream.

Draelos ZD. Draelos ZD. Dermatol Surg. 2005 Jul;31(7 Pt 2):799-804. doi: 10.1111/j.1524-4725.2005.31723. Dermatol Surg. 2005. PMID: 16029670 Clinical Trial.

87

Nutrition and enhancing youthful-appearing skin.

Draelos ZD. Draelos ZD. Clin Dermatol. 2010 Jul-Aug;28(4):400-8. doi: 10.1016/j.clindermatol.2010.03.019. Clin Dermatol. 2010. PMID: 20620756

88

Efficacy and Safety of Tazarotene 0.045% Lotion in Caucasian Adults With Moderate-to-Severe Acne.

Del Rosso J, Stein Gold L, Tyring S, Zeichner J, Callender V, Draelos Z, Werschler W, Cook-Bolden F, Guenin E. Del Rosso J, et al. J Drugs Dermatol. 2022 Oct 1;21(10):1061-1069. doi: 10.36849/JDD.6834. J Drugs Dermatol. 2022. PMID: 36219057 Clinical Trial.

89

Commentary on Defining Skin Quality: Clinical Relevance, Terminology, and Assessment.

Draelos ZD. Draelos ZD. Dermatol Surg. 2021 Jul 1;47(7):982-983. doi: 10.1097/DSS.0000000000003049. Dermatol Surg. 2021. PMID: 33899796 No abstract available.

90

Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.

Gollnick HP, Draelos Z, Glenn MJ, Rosoph LA, Kaszuba A, Cornelison R, Gore B, Liu Y, Graeber M; Adapalene-BPO Study Group. Gollnick HP, et al. Br J Dermatol. 2009 Nov;161(5):1180-9. doi: 10.1111/j.1365-2133.2009.09209.x. Epub 2009 May 21. Br J Dermatol. 2009. PMID: 19466959 Clinical Trial.

91

A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial.

Blauvelt A, Papp K, Gottlieb A, Jarell A, Reich K, Maari C, Gordon KB, Ferris LK, Langley RG, Tada Y, Lima RG, Elmaraghy H, Gallo G, Renda L, Park SY, Burge R, Bagel J; IXORA-R Study Group. Blauvelt A, et al. Br J Dermatol. 2020 Jun;182(6):1348-1358. doi: 10.1111/bjd.18851. Epub 2020 Jan 15. Br J Dermatol. 2020. PMID: 31887225 Free PMC article. Clinical Trial.

92

Clinical Evaluation of a Nature-Based Bakuchiol Anti-Aging Moisturizer for Sensitive Skin.

Draelos ZD, Gunt H, Zeichner J, Levy S. Draelos ZD, et al. J Drugs Dermatol. 2020 Dec 1;19(12):1181-1183. doi: 10.36849/JDD.2020.5522. J Drugs Dermatol. 2020. PMID: 33346506 Clinical Trial.

93

A Randomized Controlled Study of a Novel Botanical Acne Spot Treatment.

Barak-Shinar D, Draelos ZD. Barak-Shinar D, et al. Among authors: draelos zd. J Drugs Dermatol. 2017 Jun 1;16(6):599-603. J Drugs Dermatol. 2017. PMID: 28686778 Clinical Trial.

94

Human Stem Cell-Derived Skin Progenitors Produce Alpha 2-HS Glycoprotein (Fetuin): A Revolutionary Cosmetic Ingredient.

Nistor G, Poole AJ, Draelos Z, Lupo M, Tzikas T, Liu JH, Keirstead HS. Nistor G, et al. J Drugs Dermatol. 2016 May 1;15(5):583-98. J Drugs Dermatol. 2016. PMID: 27168267 Clinical Trial.

95

Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial.

Kircik LH, DuBois J, Draelos ZD, Werschler P, Grande K, Cook-Bolden FE, Weng E, Berk DR, Ahluwalia G. Kircik LH, et al. Among authors: draelos zd. J Drugs Dermatol. 2018 Jan 1;17(1):97-105. J Drugs Dermatol. 2018. PMID: 29320594 Clinical Trial.

96

Facilitating facial retinization through barrier improvement.

Draelos ZD, Ertel KD, Berge CA. Draelos ZD, et al. Cutis. 2006 Oct;78(4):275-81. Cutis. 2006. PMID: 17121065 Clinical Trial.

97

What defines aging?

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2009 Dec;8(4):237-8. doi: 10.1111/j.1473-2165.2009.00472.x. J Cosmet Dermatol. 2009. PMID: 19958425 No abstract available.

98

Shampoos, conditioners, and camouflage techniques.

Draelos ZD. Draelos ZD. Dermatol Clin. 2013 Jan;31(1):173-8. doi: 10.1016/j.det.2012.08.004. Epub 2012 Oct 2. Dermatol Clin. 2013. PMID: 23159186 Review.

99

Living longer, looking lovely.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2010 Jun;9(2):77-8. doi: 10.1111/j.1473-2165.2010.00501.x. J Cosmet Dermatol. 2010. PMID: 20618551 No abstract available.

100

A re-evaluation of the comedogenicity concept.

Draelos ZD, DiNardo JC. Draelos ZD, et al. J Am Acad Dermatol. 2006 Mar;54(3):507-12. doi: 10.1016/j.jaad.2005.11.1058. J Am Acad Dermatol. 2006. PMID: 16488305

101

Age-related ENOX protein (arNOX) activity correlated with oxidative skin damage in the elderly.

Morré DM, Meadows C, Hostetler B, Weston N, Kern D, Draelos Z, Morré DJ. Morré DM, et al. Biofactors. 2008;34(3):237-44. doi: 10.3233/BIO-2009-1077. Biofactors. 2008. PMID: 19734125

102

Assessing the Value of Botanical Anti-Inflammatory Agents in an OTC Acne Treatment Regimen.

Draelos ZD. Draelos ZD. J Drugs Dermatol. 2015 Dec;14(12):1418-21. J Drugs Dermatol. 2015. PMID: 26659934 Clinical Trial.

103

Hydrogel barrier/repair creams and contact dermatitis.

Draelos ZD. Draelos ZD. Am J Contact Dermat. 2000 Dec;11(4):222-5. doi: 10.1053/ajcd.2000.8586. Am J Contact Dermat. 2000. PMID: 11123415 Clinical Trial.

104

New channels for old cosmeceuticals: aquaporin modulation.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2008 Jun;7(2):83. doi: 10.1111/j.1473-2165.2008.00367.x. J Cosmet Dermatol. 2008. PMID: 18482008 No abstract available.

105

Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.

Tanghetti E, Dhawan S, Green L, Del Rosso J, Draelos Z, Leyden J, Shalita A, Glaser DA, Grimes P, Webster G, Barnett P, Le Gall N. Tanghetti E, et al. J Drugs Dermatol. 2010 May;9(5):549-58. J Drugs Dermatol. 2010. PMID: 20480800 Clinical Trial.

106

A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.

Zaenglein AL, Shamban A, Webster G, Del Rosso J, Dover JS, Swinyer L, Stein L, Lin X, Draelos Z, Gold M, Thiboutot D. Zaenglein AL, et al. J Drugs Dermatol. 2013 Jun 1;12(6):619-25. J Drugs Dermatol. 2013. PMID: 23839176 Clinical Trial.

107

Differences in Cutaneous Irritation of Five Commonly Used Topical Products.

Draelos ZD. Draelos ZD. J Drugs Dermatol. 2016 Jul 1;15(7):870-3. J Drugs Dermatol. 2016. PMID: 27391638

108

The combination of 2% 4-hydroxyanisole (mequinol) and 0.01% tretinoin effectively improves the appearance of solar lentigines in ethnic groups.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2006 Sep;5(3):239-44. doi: 10.1111/j.1473-2165.2006.00260.x. J Cosmet Dermatol. 2006. PMID: 17177746 Clinical Trial.

109

An animal model assessment of common dye-induced allergic contact dermatitis.

Dinardo J, Draelos ZD. Dinardo J, et al. Among authors: draelos zd. J Cosmet Sci. 2007 May-Jun;58(3):209-14. J Cosmet Sci. 2007. PMID: 17598023

110

Commentary on Collagenase Clostridium Histolyticum-Aaes for the Treatment of Cellulite in Women: Results From 2 Phase 3 Randomized, Placebo-Controlled Trials.

Draelos ZD. Draelos ZD. Dermatol Surg. 2021 May 1;47(5):657. doi: 10.1097/DSS.0000000000002968. Dermatol Surg. 2021. PMID: 33625138 No abstract available.

111

The effect of vehicle formulation on acne medication tolerability.

Draelos ZD, Callender V, Young C, Dhawan SS. Draelos ZD, et al. Cutis. 2008 Oct;82(4):281-4. Cutis. 2008. PMID: 19055172

112

Azelaic acid foam 15% in the treatment of papulopustular rosacea: a randomized, double-blind, vehicle-controlled study.

Draelos ZD, Elewski B, Staedtler G, Havlickova B. Draelos ZD, et al. Cutis. 2013 Dec;92(6):306-17. Cutis. 2013. PMID: 24416747 Clinical Trial.

113

A phase 3 randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of papulopustular rosacea.

Draelos ZD, Elewski BE, Harper JC, Sand M, Staedtler G, Nkulikiyinka R, Shakery K. Draelos ZD, et al. Cutis. 2015 Jul;96(1):54-61. Cutis. 2015. PMID: 26244354 Clinical Trial.

114

New developments in cosmetics and skin care products.

Draelos ZD. Draelos ZD. Adv Dermatol. 1997;12:3-17; discussion 18. Adv Dermatol. 1997. PMID: 8973733 Review.

115

Genetic mosaicism and Fitzpatrick skin type.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2011 Sep;10(3):169-70. doi: 10.1111/j.1473-2165.2011.00577.x. J Cosmet Dermatol. 2011. PMID: 21896125 No abstract available.

116

Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized study.

Lowe N, Horwitz S, Tanghetti E, Draelos Z, Menter A. Lowe N, et al. J Cosmet Laser Ther. 2006 Sep;8(3):121-7. doi: 10.1080/14764170600895237. J Cosmet Laser Ther. 2006. PMID: 16971360 Clinical Trial.

117

Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.

Stein L, Kircik L, Fowler J, Tan J, Draelos Z, Fleischer A, Appell M, Steinhoff M, Lynde C, Liu H, Jacovella J. Stein L, et al. J Drugs Dermatol. 2014 Mar;13(3):316-23. J Drugs Dermatol. 2014. PMID: 24595578 Clinical Trial.

118

Vehicle Effects on the Rosacea Skin Barrier.

Draelos ZD. Draelos ZD. J Drugs Dermatol. 2021 Jun 1;20(6):630-632. doi: 10.36849/JDD.2021.6105. J Drugs Dermatol. 2021. PMID: 34076389 Clinical Trial.

119

Special considerations in eye cosmetics.

Draelos ZD. Draelos ZD. Clin Dermatol. 2001 Jul-Aug;19(4):424-30. doi: 10.1016/s0738-081x(01)00204-8. Clin Dermatol. 2001. PMID: 11535383 Review. No abstract available.

120

A dermatologist's perspective on the final sunscreen monograph.

Draelos ZD. Draelos ZD. J Am Acad Dermatol. 2001 Jan;44(1):109-10. doi: 10.1067/mjd.2001.110654. J Am Acad Dermatol. 2001. PMID: 11148485

121

To smell or not to smell? That is the question!

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2013 Mar;12(1):1-2. doi: 10.1111/jocd.12028. J Cosmet Dermatol. 2013. PMID: 23438135 No abstract available.

122

Ability of moisturizers to reduce dry skin and irritation and to prevent their return.

Simion FA, Abrutyn ES, Draelos ZD. Simion FA, et al. Among authors: draelos zd. J Cosmet Sci. 2005 Nov-Dec;56(6):427-44. J Cosmet Sci. 2005. PMID: 16538297

123

Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.

Eichenfield LF, Draelos Z, Lucky AW, Hebert AA, Sugarman J, Stein Gold L, Rudisill D, Liu H, Manna V. Eichenfield LF, et al. J Drugs Dermatol. 2013 Jun 1;12(6):611-8. J Drugs Dermatol. 2013. PMID: 23839175 Clinical Trial.

124

Standard management options for rosacea, part 1: overview and broad spectrum of care.

Odom R, Dahl M, Dover J, Draelos Z, Drake L, Macsai M, Powell F, Thiboutot D, Webster GF, Wilkin J; National Rosacea Society Expert Committee on the Classification and Staging of Roasacea. Odom R, et al. Cutis. 2009 Jul;84(1):43-7. Cutis. 2009. PMID: 19743724

125

Oral Sarecycline for Treatment of Papulopustular Rosacea: Results of a Pilot Study of Effectiveness and Safety.

Rosso JQ, Draelos ZD, Effron C, Kircik LH. Rosso JQ, et al. Among authors: draelos zd. J Drugs Dermatol. 2021 Apr 1;20(4):426-431. doi: 10.36849/JDD.2021.5923. J Drugs Dermatol. 2021. PMID: 33852248 Clinical Trial.

126

Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: a randomized trial.

Leyden J, Lowe N, Kakita L, Draelos Z. Leyden J, et al. Cutis. 2001 Jun;67(6 Suppl):10-6. Cutis. 2001. PMID: 11499327 Clinical Trial.

127

Standard management options for rosacea, part 2: options according to subtype.

Odom R, Dahl M, Dover J, Draelos Z, Drake L, Macsai M, Powell F, Thiboutot D, Webster GF, Wilkin J; National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. Odom R, et al. Cutis. 2009 Aug;84(2):97-104. Cutis. 2009. PMID: 19746768

128

Cosmetics, skin care products, and the dermatologic surgeon. Postsurgical selection of cleansing products.

Draelos ZD. Draelos ZD. Dermatol Surg. 1998 May;24(5):543-6. doi: 10.1111/j.1524-4725.1998.tb04204.x. Dermatol Surg. 1998. PMID: 9598009 Review.

129

Assessment of skin barrier function in rosacea patients with a novel 1% metronidazole gel.

Draelos ZD. Draelos ZD. J Drugs Dermatol. 2005 Sep-Oct;4(5):557-62. J Drugs Dermatol. 2005. PMID: 16167413 Review.

130

Insight into skin lightening cosmeceuticals for women of color.

Badreshia-Bansal S, Draelos ZD. Badreshia-Bansal S, et al. Among authors: draelos zd. J Drugs Dermatol. 2007 Jan;6(1):32-9. J Drugs Dermatol. 2007. PMID: 17373159 Review.

131

Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy.

Draelos ZD, Tanghetti EA; Tazarotene Combination Leads to Efficacious Acne Results (CLEAR) Trial Study Group. Draelos ZD, et al. Cutis. 2002 Feb;69(2 Suppl):20-9. Cutis. 2002. PMID: 12095065 Clinical Trial.

132

Efficacy of Topical Botanical Treatment of Children With Mild to Moderate Atopic Dermatitis.

Draelos ZD, Traub M, Gold MH, Green LJ, Amster M, Barak-Shinar D, Kircik LH. Draelos ZD, et al. J Drugs Dermatol. 2019 Oct 1;18(10):1038-1045. J Drugs Dermatol. 2019. PMID: 31584783 Clinical Trial.

133

Development of a Tape-Stripping Liquid Chromatography-Mass Spectrometry Method for Evaluating Skin Deposition of Topical Tazarotene.

Draelos ZD, Draelos MM. Draelos ZD, et al. Among authors: draelos mm. J Drugs Dermatol. 2021 Oct 1;20(10):1105-1111. doi: 10.36849/JDD.6211. J Drugs Dermatol. 2021. PMID: 34636513

134

Halobetasol 0.01%/Tazarotene 0.045% Lotion for Moderate-to-Severe Psoriasis: Pooled Phase 3 Analysis of Males and Females.

Stein Gold L, Elewski B, Draelos Z, Jacobson A, Lin T. Stein Gold L, et al. J Drugs Dermatol. 2020 May 1;19(5):504-514. J Drugs Dermatol. 2020. PMID: 32484629 Clinical Trial.

135

The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.

Kaufman-Janette J, Avelar RL, Biesman BS, Draelos ZD, Gross JE, Jones DH, Lupo MP, Maas CS, Schlessinger J, Shamban AT, Sundaram H, Weinkle SH, Young VL. Kaufman-Janette J, et al. Among authors: draelos zd. Aesthet Surg J. 2021 Nov 12;41(12):1409-1422. doi: 10.1093/asj/sjaa383. Aesthet Surg J. 2021. PMID: 33944905 Free PMC article. Clinical Trial.

136

The rationale for advancing the formulation of azelaic acid vehicles.

Draelos ZD. Draelos ZD. Cutis. 2006 Feb;77(2 Suppl):7-11. Cutis. 2006. PMID: 16566282 Review.

137

Cosmeceuticals for Male Skin.

Draelos ZD. Draelos ZD. Dermatol Clin. 2018 Jan;36(1):17-20. doi: 10.1016/j.det.2017.09.003. Dermatol Clin. 2018. PMID: 29108541 Review.

138

Topical and oral estrogens revisited for antiaging purposes.

Draelos ZD. Draelos ZD. Fertil Steril. 2005 Aug;84(2):291-2; discussion 295. doi: 10.1016/j.fertnstert.2005.03.033. Fertil Steril. 2005. PMID: 16084864 Free article. Review.

139

Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.

Kaufman-Janette J, Avelar RL, Biesman BS, Draelos ZD, Gross JE, Jones DH, Lupo MP, Maas CS, Schlessinger J, Shamban AT, Sundaram H, Weinkle SH, Young VL. Kaufman-Janette J, et al. Among authors: draelos zd. Aesthet Surg J. 2021 Nov 12;41(12):1494. doi: 10.1093/asj/sjab229. Aesthet Surg J. 2021. PMID: 34309676 Free PMC article. No abstract available.

140

SUPPLEMENT ARTICLE: Scientific and Clinical Insights into the Facial Application of Mineralizing Volcanic Water.

Kircik L, Callender V, Draelos Z, Hooper D, Jagdeo J, Lain E, Zeichner J, Enright K. Kircik L, et al. J Drugs Dermatol. 2022 Apr 1;21(4):s3-s10. J Drugs Dermatol. 2022. PMID: 35389591

141

Cosmeceuticals: efficacy and influence on skin tone.

Draelos ZD. Draelos ZD. Dermatol Clin. 2014 Apr;32(2):137-43. doi: 10.1016/j.det.2013.12.002. Epub 2014 Jan 22. Dermatol Clin. 2014. PMID: 24680000 Review.

142

Evaluation of an onion extract, Centella asiatica, and hyaluronic acid cream in the appearance of striae rubra.

Draelos ZD, Gold MH, Kaur M, Olayinka B, Grundy SL, Pappert EJ, Hardas B. Draelos ZD, et al. Skinmed. 2010 Mar-Apr;8(2):80-6. Skinmed. 2010. PMID: 20527138 Clinical Trial.

143

Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.

Stein Gold L, Kircik L, Fowler J, Jackson JM, Tan J, Draelos Z, Fleischer A, Appell M, Steinhoff M, Lynde C, Sugarman J, Liu H, Jacovella J; Ivermectin Phase 3 Study Group. Stein Gold L, et al. J Drugs Dermatol. 2014 Nov;13(11):1380-6. J Drugs Dermatol. 2014. PMID: 25607706 Clinical Trial.

144

What is anti-aging?

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2007 Jun;6(2):73-4. doi: 10.1111/j.1473-2165.2007.00309.x. J Cosmet Dermatol. 2007. PMID: 17524121 No abstract available.

145

Antipruritic hydrogel for the treatment of atopic dermatitis: an open-label pilot study.

Draelos ZD. Draelos ZD. Cutis. 2012 Aug;90(2):97-102. Cutis. 2012. PMID: 22988654 Clinical Trial.

146

Reinvigorating cosmetic dermatology with the nanoparticle revolution.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2011 Dec;10(4):251-2. doi: 10.1111/j.1473-2165.2011.00591.x. J Cosmet Dermatol. 2011. PMID: 22151931 No abstract available.

147

The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.

Lorenc ZP, Adelglass JM, Avelar RL, Baumann L, Beer KR, Cohen JL, Cox SE, Dayan SH, Dover JS, Downie JB, Draelos ZD, Goldman MP, Gross JE, Joseph JH, Kaufman-Janette J, Moy RL, Nestor M, Schlessinger J, Smith SR, Weiss RA. Lorenc ZP, et al. Among authors: draelos zd. Aesthet Surg J. 2021 Nov 12;41(12):1423-1438. doi: 10.1093/asj/sjaa382. Aesthet Surg J. 2021. PMID: 33944913 Free PMC article. Clinical Trial.

148

Development of a Photonumeric Lip Health Scale.

Draelos ZD, Rigel D, Friedman A. Draelos ZD, et al. J Drugs Dermatol. 2020 Jun 1;19(6):632-636. doi: 10.36849/JDD.2020.10.36849/JDD.2020.5139. J Drugs Dermatol. 2020. PMID: 32574022

149

A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis.

Herzog JL, Solomon JA, Draelos Z, Fleischer A Jr, Stough D, Wolf DI, Abramovits W, Werschler W, Green E, Duffy M, Rothaul A, Tansley R. Herzog JL, et al. J Drugs Dermatol. 2011 Aug;10(8):853-60. J Drugs Dermatol. 2011. PMID: 21818506 Clinical Trial.

150

The dermatology dispensing debate.

Draelos ZD. Draelos ZD. Skin Therapy Lett. 2007 Nov;12(9):1-3. Skin Therapy Lett. 2007. PMID: 18087657 Free article.

151

Physicians' and patients' perspectives on office-based dispensing: the central role of the physician-patient relationship.

Ogbogu P, Fleischer AB Jr, Brodell RT, Bhalla G, Draelos ZD, Feldman SR. Ogbogu P, et al. Among authors: draelos zd. Arch Dermatol. 2001 Feb;137(2):151-4. Arch Dermatol. 2001. PMID: 11176686

152

Creating an attractive aging face.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2012 Sep;11(3):167-8. doi: 10.1111/j.1473-2165.2012.00632.x. J Cosmet Dermatol. 2012. PMID: 22937999 No abstract available.

153

Genomics: the future of cosmetic dermatology.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2010 Dec;9(4):265-6. doi: 10.1111/j.1473-2165.2010.00519.x. J Cosmet Dermatol. 2010. PMID: 21122043 No abstract available.

154

Cosmeceuticals: What's Real, What's Not.

Draelos ZD. Draelos ZD. Dermatol Clin. 2019 Jan;37(1):107-115. doi: 10.1016/j.det.2018.07.001. Epub 2018 Nov 1. Dermatol Clin. 2019. PMID: 30466682 Review.

155

Novel Facial Treatment Regimen Improves Aging Skin Appearance.

Farris P, Draelos ZD, Felipe de Oliveira Stehling L. Farris P, et al. Among authors: draelos zd. J Drugs Dermatol. 2021 Mar 1;20(3):274-278. doi: 10.36849/JDD.5791. J Drugs Dermatol. 2021. PMID: 33683078 Clinical Trial.

156

Treating the patient with multiple cosmetic product allergies. A problem-oriented approach to sensitive skin.

Draelos ZD. Draelos ZD. Postgrad Med. 2000 Jun;107(7):70-2, 75-7. doi: 10.3810/pgm.2000.06.1109. Postgrad Med. 2000. PMID: 10887447 Review.

157

An Open Label Clinical Trial of a Peptide Treatment Serum and Supporting Regimen Designed to Improve the Appearance of Aging Facial Skin.

Draelos ZD, Kononov T, Fox T. Draelos ZD, et al. J Drugs Dermatol. 2016 Sep 1;15(9):1100-6. J Drugs Dermatol. 2016. PMID: 27602972 Clinical Trial.

158

Colored facial cosmetics.

Draelos ZD. Draelos ZD. Dermatol Clin. 2000 Oct;18(4):621-31. doi: 10.1016/s0733-8635(05)70213-8. Dermatol Clin. 2000. PMID: 11059370

159

The biology of hair care.

Draelos ZD. Draelos ZD. Dermatol Clin. 2000 Oct;18(4):651-8. doi: 10.1016/s0733-8635(05)70216-3. Dermatol Clin. 2000. PMID: 11059373 Review.

160

Evaluating consumer dermatologic devices.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2009 Jun;8(2):75-6. doi: 10.1111/j.1473-2165.2009.00427.x. J Cosmet Dermatol. 2009. PMID: 19527328 No abstract available.

161

Nail Cosmetics and Adornment.

Draelos ZD. Draelos ZD. Dermatol Clin. 2021 Apr;39(2):351-359. doi: 10.1016/j.det.2021.01.001. Dermatol Clin. 2021. PMID: 33745645 Review.

162

Treating beyond the histology of rosacea.

Draelos ZD. Draelos ZD. Cutis. 2004 Sep;74(3 Suppl):28-31, 32-4. Cutis. 2004. PMID: 15499756 Review.

163

Cosmetics and skin care products. A historical perspective.

Draelos ZD. Draelos ZD. Dermatol Clin. 2000 Oct;18(4):557-9. doi: 10.1016/s0733-8635(05)70206-0. Dermatol Clin. 2000. PMID: 11059363

164

Eating for a lifetime of healthy skin.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2011 Mar;10(1):1-2. doi: 10.1111/j.1473-2165.2011.00546.x. J Cosmet Dermatol. 2011. PMID: 21332908 No abstract available.

165

Clinical situations conducive to proactive barrier enhancement.

Draelos ZD. Draelos ZD. Cutis. 2002 Dec;70(6 Suppl):17-20; discussion 21-3. Cutis. 2002. PMID: 12498534 Review. No abstract available.

166

Science and the validation of cosmeceutical formulations.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2014 Sep;13(3):167-8. doi: 10.1111/jocd.12105. J Cosmet Dermatol. 2014. PMID: 25196682 No abstract available.

167

Male skin and ingredients relevant to male skin care.

Draelos ZD. Draelos ZD. Br J Dermatol. 2012 Mar;166 Suppl 1:13-6. doi: 10.1111/j.1365-2133.2011.10784.x. Br J Dermatol. 2012. PMID: 22385030 Review.

168

Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis.

Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, Antoni C, Draelos Z, Gold MH; Psoriasis Study Group; Durez P, Tak PP, Gomez-Reino JJ; Rheumatoid Arthritis Study Group; Foster CS, Kim RY, Samson CM, Falk NS, Chu DS, Callanan D, Nguyen QD; Uveitis Study Group; Rose K, Haider A, Di Padova F. Hueber W, et al. Sci Transl Med. 2010 Oct 6;2(52):52ra72. doi: 10.1126/scitranslmed.3001107. Sci Transl Med. 2010. PMID: 20926833 Clinical Trial.

169

Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee.

Thiboutot D, Anderson R, Cook-Bolden F, Draelos Z, Gallo RL, Granstein RD, Kang S, Macsai M, Gold LS, Tan J. Thiboutot D, et al. J Am Acad Dermatol. 2020 Jun;82(6):1501-1510. doi: 10.1016/j.jaad.2020.01.077. Epub 2020 Feb 7. J Am Acad Dermatol. 2020. PMID: 32035944 Review.

170

Topical Oxymetazoline Cream 1.0% for Persistent Facial Erythema Associated With Rosacea: Pooled Analysis of the Two Phase 3, 29-Day, Randomized, Controlled REVEAL Trials.

Stein-Gold L, Kircik L, Draelos ZD, Werschler P, DuBois J, Lain E, Baumann L, Goldberg D, Kaufman J, Tanghetti E, Ahluwalia G, Alvandi N, Weng E, Berk D. Stein-Gold L, et al. Among authors: draelos zd. J Drugs Dermatol. 2018 Nov 1;17(11):1201-1208. J Drugs Dermatol. 2018. PMID: 30500142 Clinical Trial.

171

The multifunctionality of 10% sodium sulfacetamide, 5% sulfur emollient foam in the treatment of inflammatory facial dermatoses.

Draelos ZD. Draelos ZD. J Drugs Dermatol. 2010 Mar;9(3):234-6. J Drugs Dermatol. 2010. PMID: 20232584

172

Hair care and dyeing.

Draelos ZD. Draelos ZD. Curr Probl Dermatol. 2015;47:121-7. doi: 10.1159/000369412. Epub 2015 Feb 20. Curr Probl Dermatol. 2015. PMID: 26370650 Review.

173

Clinical Benefits of Circadian-based Antioxidant Protection and Repair.

Draelos ZD, Makino ET, Kadoya K, Nguyen A, Jiang LI, Mehta RC. Draelos ZD, et al. J Drugs Dermatol. 2020 Dec 1;19(12):1209-1214. doi: 10.36849/JDD.2020.5355. J Drugs Dermatol. 2020. PMID: 33346522 Clinical Trial.

174

The multifunctional value of sunscreen-containing cosmetics.

Draelos ZD. Draelos ZD. Skin Therapy Lett. 2011 Jul-Aug;16(7):1-3. Skin Therapy Lett. 2011. PMID: 21833463 Free article.

175

Active agents in common skin care products.

Draelos ZD. Draelos ZD. Plast Reconstr Surg. 2010 Feb;125(2):719-724. doi: 10.1097/PRS.0b013e3181c83192. Plast Reconstr Surg. 2010. PMID: 20124857 Review.

176

Are cosmetics safe?

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2012 Dec;11(4):249-50. doi: 10.1111/jocd.12014. J Cosmet Dermatol. 2012. PMID: 23174046 No abstract available.

177

Hydrocortisone butyrate 0.1% lotion in the treatment of atopic dermatitis in pediatric subjects.

Matheson R, Kempers S, Breneman D, Draelos Z, Johnson CE, Loss R, Hogan DJ, Schoenfeld R, Checketts S, Kircik L, Fivenson D, Hebert AA, Williams J, Hamlin R, Groisser D, Piacquadio D. Matheson R, et al. J Drugs Dermatol. 2008 Mar;7(3):266-71. J Drugs Dermatol. 2008. PMID: 18380208 Clinical Trial.

178

Nail cosmetic issues.

Draelos ZD. Draelos ZD. Dermatol Clin. 2000 Oct;18(4):675-83, x. doi: 10.1016/s0733-8635(05)70219-9. Dermatol Clin. 2000. PMID: 11059376 Review.

179

Aging in a polluted world.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2014 Jun;13(2):85. doi: 10.1111/jocd.12092. J Cosmet Dermatol. 2014. PMID: 24910269 No abstract available.

180

Camouflaging techniques and dermatologic surgery.

Draelos ZD. Draelos ZD. Dermatol Surg. 1996 Dec;22(12):1023-7. doi: 10.1111/j.1524-4725.1996.tb00655.x. Dermatol Surg. 1996. PMID: 9078314

181

Cosmetics, categories, and the future.

Draelos ZD. Draelos ZD. Dermatol Ther. 2012 May-Jun;25(3):223-8. doi: 10.1111/j.1529-8019.2012.01498.x. Dermatol Ther. 2012. PMID: 22913438

182

Abbreviations for device names: a proposed methodology with specific examples.

Alam M, Dover JS; American Society for Dermatologic Surgery Lexicon Task Force; Subsection chairs:; Alam M, Goldman MP, Kaminer MS, Orringer J, Waldorf H, Alam M, Avram M, Cohen JL, Draelos ZD, Dover JS, Hruza G, Kilmer S, Lawrence N, Lupo M, Metelitsa A, Nestor M, Ross EV. Alam M, et al. Among authors: draelos zd. Dermatol Surg. 2013 Apr;39(4):548-50. doi: 10.1111/dsu.12156. Epub 2013 Feb 22. Dermatol Surg. 2013. PMID: 23433100

183

Robotic cosmetic dermatology.

Draelos MT, Draelos ZD. Draelos MT, et al. Among authors: draelos zd. J Cosmet Dermatol. 2011 Jun;10(2):87-8. doi: 10.1111/j.1473-2165.2011.00559.x. J Cosmet Dermatol. 2011. PMID: 21649811 No abstract available.

184

A comparison of hair quality and cosmetic acceptance following the use of two anti-dandruff shampoos.

Draelos ZD, Kenneally DC, Hodges LT, Billhimer W, Copas M, Margraf C. Draelos ZD, et al. J Investig Dermatol Symp Proc. 2005 Dec;10(3):201-4. doi: 10.1111/j.1087-0024.2005.10127.x. J Investig Dermatol Symp Proc. 2005. PMID: 16382664 Free article. Clinical Trial.

185

Retaining the professionalism of cosmetic dermatology.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2006 Dec;5(4):273. doi: 10.1111/j.1473-2165.2006.00268.x. J Cosmet Dermatol. 2006. PMID: 17716242 No abstract available.

186

The rise of cosmetic dermatology in the new medical model.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2012 Mar;11(1):1-2. doi: 10.1111/j.1473-2165.2012.00604.x. J Cosmet Dermatol. 2012. PMID: 22360327 No abstract available.

187

The biofilm, injectables, and cosmetic dermatology.

Draelos MM, Draelos ZD. Draelos MM, et al. Among authors: draelos zd. J Cosmet Dermatol. 2013 Dec;12(4):245-6. doi: 10.1111/jocd.12069. J Cosmet Dermatol. 2013. PMID: 24305421 No abstract available.

188

The international cosmetic dermatologic community: trends and controversies.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2008 Sep;7(3):163. doi: 10.1111/j.1473-2165.2008.00383.x. J Cosmet Dermatol. 2008. PMID: 18789049 No abstract available.

189

The cosmetic dose: how much are you getting?

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2013 Sep;12(3):169. doi: 10.1111/jocd.12054. J Cosmet Dermatol. 2013. PMID: 23992157 No abstract available.

190

The biofilm: skin health and beauty in a contaminated world.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2010 Sep;9(3):167-8. doi: 10.1111/j.1473-2165.2010.00517.x. J Cosmet Dermatol. 2010. PMID: 20883288 No abstract available.

191

Vehicle Formulation Impacts Tolerability and Patient Preference: Comparison of Tretinoin Branded Lotion and Generic Cream.

Draelos Z, Tanghetti E, Guenin E. Draelos Z, et al. J Drugs Dermatol. 2022 Aug 1;21(8):875-880. doi: 10.36849/JDD.6945. J Drugs Dermatol. 2022. PMID: 35946981 Clinical Trial.

192

Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea.

Draelos ZD, Ertel K, Berge C. Draelos ZD, et al. Cutis. 2005 Aug;76(2):135-41. Cutis. 2005. PMID: 16209160 Clinical Trial.

193

Clinical situations conducive to proactive skin health and anti-aging improvement.

Draelos ZD. Draelos ZD. J Investig Dermatol Symp Proc. 2008 Apr;13(1):25-7. doi: 10.1038/jidsymp.2008.9. J Investig Dermatol Symp Proc. 2008. PMID: 18369336 Free article. Review.

194

Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.

Draelos ZD, Potts A, Alió Saenz AB; W0265-306 Study Group. Draelos ZD, et al. Cutis. 2010 Dec;86(6):310-8. Cutis. 2010. PMID: 21284283 Clinical Trial.

195

Natural Skin Care Products as Adjunctive to Prescription Therapy in Moderate to Severe Rosacea.

Draelos ZD, Gunt H, Levy SB. Draelos ZD, et al. J Drugs Dermatol. 2019 Feb 1;18(2):141-146. J Drugs Dermatol. 2019. PMID: 30794364 Clinical Trial.

196

Vehicles for atopic dermatitis therapies: more than just a placebo.

Danby SG, Draelos ZD, Gold LFS, Cha A, Vlahos B, Aikman L, Sanders P, Wu-Linhares D, Cork MJ. Danby SG, et al. Among authors: draelos zd. J Dermatolog Treat. 2022 Mar;33(2):685-698. doi: 10.1080/09546634.2020.1789050. Epub 2020 Jul 16. J Dermatolog Treat. 2022. PMID: 32654550 Free article. Review.

197

A Novel Approach to Enhancing the Quality and Appearance of Photoaged Skin.

Draelos ZD. Draelos ZD. J Drugs Dermatol. 2019 Jan 1;18(1):28-31. J Drugs Dermatol. 2019. PMID: 30681790 Clinical Trial.

198

Hair, sun, regulation, and beauty.

Draelos ZD. Draelos ZD. J Cosmet Dermatol. 2014 Mar;13(1):1-2. doi: 10.1111/jocd.12080. J Cosmet Dermatol. 2014. PMID: 24641599 No abstract available.

199

Finasteride in the treatment of men with frontal male pattern hair loss.

Leyden J, Dunlap F, Miller B, Winters P, Lebwohl M, Hecker D, Kraus S, Baldwin H, Shalita A, Draelos Z, Markou M, Thiboutot D, Rapaport M, Kang S, Kelly T, Pariser D, Webster G, Hordinsky M, Rietschel R, Katz HI, Terranella L, Best S, Round E, Waldstreicher J. Leyden J, et al. J Am Acad Dermatol. 1999 Jun;40(6 Pt 1):930-7. doi: 10.1016/s0190-9622(99)70081-2. J Am Acad Dermatol. 1999. PMID: 10365924 Clinical Trial.

200

DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2).

Carruthers JD, Fagien S, Joseph JH, Humphrey SD, Biesman BS, Gallagher CJ, Liu Y, Rubio RG; SAKURA 1 and SAKURA 2 Investigator Group; SAKURA 1 and SAKURA 2 Investigator Group includes the following. Carruthers JD, et al. Plast Reconstr Surg. 2020 Jan;145(1):45-58. doi: 10.1097/PRS.0000000000006327. Plast Reconstr Surg. 2020. PMID: 31609882 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results